0001209191-20-053886.txt : 20201005 0001209191-20-053886.hdr.sgml : 20201005 20201005191023 ACCESSION NUMBER: 0001209191-20-053886 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201001 FILED AS OF DATE: 20201005 DATE AS OF CHANGE: 20201005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goldberg John Mayer CENTRAL INDEX KEY: 0001826549 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39575 FILM NUMBER: 201225059 MAIL ADDRESS: STREET 1: C/O ONCORUS, INC. STREET 2: 50 HAMPSHIRE STREET, SUITE 401 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncorus, Inc. CENTRAL INDEX KEY: 0001671818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473779757 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 450 KENDALL STREET STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-425-9200 MAIL ADDRESS: STREET 1: 450 KENDALL STREET STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-01 0 0001671818 Oncorus, Inc. ONCR 0001826549 Goldberg John Mayer C/O ONCORUS, INC. 50 HAMPSHIRE STREET, SUITE 401 CAMBRIDGE MA 02139 0 1 0 0 SVP, Clinical Development Employee Stock Option (right to buy) 15.00 2020-10-01 4 A 0 56285 0.00 A 2030-09-14 Common Stock 56285 56285 D Twenty-five percent (25%) of the shares subject to the option shall vest on September 15, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. /s/ Jason Minio, Attorney-in-Fact 2020-10-05